Anemia, Aplastic [clinicaltrials_resource:efdcec7dd8d1fb1d4783d9d3e6bc7e11]
Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders [clinicaltrials:NCT00000597]Cord Blood Stem Cell Transplantation Study (COBLT) [clinicaltrials:NCT00000603]Drug Etiology of Aplastic Anemia and Related Dyscrasias [clinicaltrials:NCT00005302]Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data [clinicaltrials:NCT00005307]Aplastic Anemia Epidemiology: Incidence and Case-control [clinicaltrials:NCT00005682]Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias [clinicaltrials:NCT00061763]Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor [clinicaltrials:NCT00144729]clinicaltrials:NCT00229619clinicaltrials:NCT00244010Identifying Characteristics of Bone Marrow Failure Syndromes [clinicaltrials:NCT00315419]clinicaltrials:NCT00319878clinicaltrials:NCT00326417clinicaltrials:NCT00393380clinicaltrials:NCT00399971Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia [clinicaltrials:NCT00578266]clinicaltrials:NCT00618969clinicaltrials:NCT00683046clinicaltrials:NCT00692926Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA) [clinicaltrials:NCT00737685]clinicaltrials:NCT00922883clinicaltrials:NCT00944749Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer [clinicaltrials:NCT00975975]clinicaltrials:NCT00997386
condition [clinicaltrials_vocabulary:condition]
Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders [clinicaltrials:NCT00000597]Cord Blood Stem Cell Transplantation Study (COBLT) [clinicaltrials:NCT00000603]Collection of Blood From Patients With Pancytopenia [clinicaltrials:NCT00001214]Stem Cell Factor Medication for Aplastic Anemia [clinicaltrials:NCT00001398]clinicaltrials:NCT00001626Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes [clinicaltrials:NCT00001627]clinicaltrials:NCT00001962clinicaltrials:NCT00001964clinicaltrials:NCT00003816clinicaltrials:NCT00004143Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia [clinicaltrials:NCT00004323]Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria [clinicaltrials:NCT00004464]Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia [clinicaltrials:NCT00004474]Drug Etiology of Aplastic Anemia and Related Dyscrasias [clinicaltrials:NCT00005302]Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data [clinicaltrials:NCT00005307]Aplastic Anemia Epidemiology: Incidence and Case-control [clinicaltrials:NCT00005682]Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia [clinicaltrials:NCT00005935]Oral Manifestations of Aplastic Anemia [clinicaltrials:NCT00006300]Protection Against Benzene Toxicity [clinicaltrials:NCT00011453]Stem Cell Mobilization Potential in Patients With Aplastic Anemia in Remission [clinicaltrials:NCT00011830]Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia [clinicaltrials:NCT00017654]Cancer in Inherited Bone Marrow Failure Syndromes [clinicaltrials:NCT00027274]Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States [clinicaltrials:NCT00038779]Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic Anemia [clinicaltrials:NCT00050115]Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Aplastic Anemia [clinicaltrials:NCT00053989]clinicaltrials:NCT00054236clinicaltrials:NCT00061360Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias [clinicaltrials:NCT00061763]clinicaltrials:NCT00065260Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor [clinicaltrials:NCT00144729]Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia [clinicaltrials:NCT00186797]clinicaltrials:NCT00195624clinicaltrials:NCT00212407clinicaltrials:NCT00229619clinicaltrials:NCT00243399clinicaltrials:NCT00244010clinicaltrials:NCT00260689Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia [clinicaltrials:NCT00295997]Identifying Characteristics of Bone Marrow Failure Syndromes [clinicaltrials:NCT00315419]clinicaltrials:NCT00319878
condition browse [clinicaltrials_vocabulary:condition-browse]
Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders [clinicaltrials:NCT00000597]Cord Blood Stem Cell Transplantation Study (COBLT) [clinicaltrials:NCT00000603]Collection of Blood From Patients With Pancytopenia [clinicaltrials:NCT00001214]Stem Cell Factor Medication for Aplastic Anemia [clinicaltrials:NCT00001398]clinicaltrials:NCT00001626Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes [clinicaltrials:NCT00001627]clinicaltrials:NCT00001962clinicaltrials:NCT00001964clinicaltrials:NCT00003816clinicaltrials:NCT00004143Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia [clinicaltrials:NCT00004323]Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria [clinicaltrials:NCT00004464]Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia [clinicaltrials:NCT00004474]Drug Etiology of Aplastic Anemia and Related Dyscrasias [clinicaltrials:NCT00005302]Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data [clinicaltrials:NCT00005307]Aplastic Anemia Epidemiology: Incidence and Case-control [clinicaltrials:NCT00005682]Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia [clinicaltrials:NCT00005935]Oral Manifestations of Aplastic Anemia [clinicaltrials:NCT00006300]Protection Against Benzene Toxicity [clinicaltrials:NCT00011453]Stem Cell Mobilization Potential in Patients With Aplastic Anemia in Remission [clinicaltrials:NCT00011830]Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia [clinicaltrials:NCT00017654]Cancer in Inherited Bone Marrow Failure Syndromes [clinicaltrials:NCT00027274]Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States [clinicaltrials:NCT00038779]Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic Anemia [clinicaltrials:NCT00050115]Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Aplastic Anemia [clinicaltrials:NCT00053989]clinicaltrials:NCT00054236clinicaltrials:NCT00061360Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias [clinicaltrials:NCT00061763]clinicaltrials:NCT00065260Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor [clinicaltrials:NCT00144729]Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia [clinicaltrials:NCT00186797]clinicaltrials:NCT00195624clinicaltrials:NCT00212407clinicaltrials:NCT00229619clinicaltrials:NCT00243399clinicaltrials:NCT00244010clinicaltrials:NCT00260689Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia [clinicaltrials:NCT00295997]Identifying Characteristics of Bone Marrow Failure Syndromes [clinicaltrials:NCT00315419]clinicaltrials:NCT00319878
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Anemia, Aplastic [clinicaltrials_resource:efdcec7dd8d1fb1d4783d9d3e6bc7e11]
Bio2RDF identifier
efdcec7dd8d1fb1d4783d9d3e6bc7e11
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:efdcec7dd8d1fb1d4783d9d3e6bc7e11
identifier
clinicaltrials_resource:efdcec7dd8d1fb1d4783d9d3e6bc7e11
title
Anemia, Aplastic
@en
type
label
Anemia, Aplastic [clinicaltrials_resource:efdcec7dd8d1fb1d4783d9d3e6bc7e11]
@en
Anemia, Aplastic